Novartis Beats Subpoenas In Jaw-Injuries Drug Suit

Law360, New York (September 17, 2013, 2:37 PM EDT) -- A Florida federal judge last week refused to permit the subpoena of two Novartis Pharmaceuticals Corp. employees, in a lawsuit concerning jaw injuries allegedly caused by the bone drugs Aredia and Zometa, saying the employees are too far from the trial location.

Plaintiff Ruth Dopson-Troutt was diagnosed with breast cancer, which later metastasized to her hip and pelvic bones, and her oncologist prescribed Aredia and Zometa from 1999 to 2005. But after Dopson-Troutt had a tooth extracted, she began experiencing jaw pain caused by osteonecrosis of the jaw, which she alleges was caused by the drugs. She wanted to subpoena two...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS